Taken together, these findings suggest that aberrant downregulation of YAP may have a role in early AD pathogenesis; it can be hypothesised that this could be perhaps by reducing healthy clearance of Aβ or tau by microglia, and/or by permitting proinflammatory microglial activation. This evidence concerns the gene MAPT and Alzheimer disease.